These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 12682762

  • 1. [Pathogenesis of choroidal neovascularization. Old concepts, new questions].
    Fauser S, Engelmann K, Krohne TU, Lappas A, Kirchhof B, Joussen AM.
    Ophthalmologe; 2003 Apr; 100(4):300-5. PubMed ID: 12682762
    [Abstract] [Full Text] [Related]

  • 2. [The molecular mechanisms of neovascular age-related macular degeneration].
    Miller DW, Joussen AM, Holz FG.
    Ophthalmologe; 2003 Feb; 100(2):92-6. PubMed ID: 12589451
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].
    Holz FG, Miller DW.
    Ophthalmologe; 2003 Feb; 100(2):97-103. PubMed ID: 12589452
    [Abstract] [Full Text] [Related]

  • 4. Which treatment is best for which AMD patient?
    Kroll P, Meyer CH.
    Br J Ophthalmol; 2006 Feb; 90(2):128-30. PubMed ID: 16424516
    [Abstract] [Full Text] [Related]

  • 5. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.
    Campochiaro PA, Soloway P, Ryan SJ, Miller JW.
    Mol Vis; 1999 Nov 03; 5():34. PubMed ID: 10562658
    [Abstract] [Full Text] [Related]

  • 6. [New therapeutic approaches to age dependent macular degeneration].
    Holz FG.
    Ophthalmologe; 2003 Feb 03; 100(2):90-1. PubMed ID: 12653082
    [No Abstract] [Full Text] [Related]

  • 7. Wet age-related macular degeneration.
    Kulkarni AD, Kuppermann BD.
    Adv Drug Deliv Rev; 2005 Dec 13; 57(14):1994-2009. PubMed ID: 16309781
    [Abstract] [Full Text] [Related]

  • 8. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A, La Heij E, Hendrikse F.
    Ocul Immunol Inflamm; 2005 Feb 13; 13(1):3-11. PubMed ID: 15804763
    [Abstract] [Full Text] [Related]

  • 9. No efficacious treatment for age-related macular degeneration.
    Roodhooft J.
    Bull Soc Belge Ophtalmol; 2000 Feb 13; 276():83-92. PubMed ID: 10925530
    [Abstract] [Full Text] [Related]

  • 10. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N, Damico L, Shams N, Lowman H, Kim R.
    Retina; 2006 Oct 13; 26(8):859-70. PubMed ID: 17031284
    [Abstract] [Full Text] [Related]

  • 11. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S, Tatar O.
    Prog Retin Eye Res; 2008 Jul 13; 27(4):372-90. PubMed ID: 18621565
    [Abstract] [Full Text] [Related]

  • 12. [Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
    Augustin AJ, Offermann I.
    Klin Monbl Augenheilkd; 2008 Jun 13; 225(6):555-63. PubMed ID: 18516776
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current treatment options for retinal angiomatous proliferans (RAP).
    Gupta B, Jyothi S, Sivaprasad S.
    Br J Ophthalmol; 2010 Jun 13; 94(6):672-7. PubMed ID: 19897475
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS.
    Am J Ophthalmol; 2006 Mar 13; 141(3):456-62. PubMed ID: 16490490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Angiogenesis in ophthalmology. A theme with a future].
    Joussen AM, Kirchhof B.
    Ophthalmologe; 2003 Apr 13; 100(4):281-3. PubMed ID: 12723577
    [No Abstract] [Full Text] [Related]

  • 20. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
    Pauleikhoff D, Bornfeld N, Gabel VP, Holz F, Roider H, German Ophthalmological Society, Retinological Society, Professional Association of Ophthalmologists.
    Klin Monbl Augenheilkd; 2005 May 13; 222(5):381-8. PubMed ID: 15912454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.